Mayzent vs. Gilenya

Are Mayzent and Gilenya the Same Thing?

Mayzent (siponimod) and Gilenya (fingolimod) are sphingosine 1-phosphate receptor modulators used to treat relapsing forms of multiple sclerosis (MS).

Side effects of Mayzent and Gilenya that are similar include headache, increased liver transaminase, and diarrhea.

Side effects of Mayzent that are different from Gilenya include high blood pressure (hypertension), falls, pain and swelling in extremities, nausea, dizziness, and slow heart rate.

Side effects of Gilenya that are different from Mayzent include tired feeling, influenza, stuffy nose, sinus pain, diarrhea, back pain, and cough.

Both Mayzent and Gilenya may interact with “live” vaccines, cancer medications, immune-modulating drugs, immunosuppressive therapies, calcium channel blockers, and beta-blockers.

Mayzent may interact with anti-arrhythmics, QT prolonging drugs, other drugs that may decrease heart rate, fluconazole, rifampin, carbamazepine, modafinil, or efavirenz.

Gilenya may interact with citalopram, chlorpromazine, digoxin, erythromycin, haloperidol, ketoconazole, heart problems, or high blood pressure, and methadone.

What Are Possible Side Effects of Mayzent?

Common side effects of Mayzent include:

  • headache,
  • high blood pressure (hypertension),
  • increased transaminase,
  • falls,
  • swelling of extremities,
  • nausea,
  • dizziness,
  • diarrhea,
  • slow heart rate, and
  • pain in extremities

What Are Possible Side Effects of Gilenya?

Common side effects of Gilenya include:

  • headache,
  • tired feeling,
  • influenza,
  • stuffy nose,
  • sinus pain,
  • diarrhea,
  • back pain,
  • liver transaminase elevations, and
  • cough.

Gilenya can affect your immune system's ability to fight an infection while you are taking the medication and for 2 months after your last dose. Tell your doctor right away if you develop signs of an infection such as:

What Is Mayzent?

Mayzent (siponimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

What Is Gilenya?

Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator used to treat patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of exacerbations and to delay physical disability.

QUESTION

What kind of disease is multiple sclerosis? See Answer

What Drugs Interact With Mayzent?

Mayzent may interact with:

  • "live" vaccines,
  • cancer medications,
  • immune-modulating drugs,
  • immunosuppressive therapies,
  • anti-arrhythmics,
  • QT prolonging drugs,
  • calcium channel blockers,
  • other drugs that may decrease heart rate,
  • beta-blockers,
  • fluconazole,
  • rifampin,
  • carbamazepine,
  • modafinil, or
  • efavirenz.

What Drugs Interact With Gilenya?

Gilenya may interact with:

  • beta-blockers,
  • calcium channel blockers,
  • citalopram,
  • chlorpromazine,
  • digoxin,
  • erythromycin,
  • haloperidol,
  • ketoconazole,
  • medications to control the immune system,
  • medications for cancer, heart problems, or high blood pressure, and
  • methadone

Tell your doctor all medications and supplements you use. Gilenya may cause fetal harm. It takes approximately 2 months for Gilenya to be eliminated from the body. Women should avoid pregnancy during treatment with Gilenya and for 2 months after treatment. It is not known if Gilenya passes into breast milk. Women and their doctors should decide whether to take Gilenya or breastfeed. Women should not do both.

How Should Mayzent Be Taken?

Initiate Mayzent with a 5-day titration. The recommended maintenance dosage of Mayzent is 2 mg.

How Should Gilenya Be Taken?

The recommended dose for Gilenya is 0.5 mg orally once daily, with or without food.

SLIDESHOW

What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Novartis AG. Mayzent Product Information.

https://www.mayzent.com

Novartis. Gilenya Product Information

https://www.gilenya.com

Health Solutions From Our Sponsors